Goodwin Procter, McDermott Will & Emery, and Mason Hayes & Curran advised LetsGetChecked, while Latham & Watkins and BakerHostetler advised Truepill on the deal. LetsGetChecked, a...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Boston Scientific Corporation in the transaction, and Wilson Sonsini Goodrich & Rosati represented Silk Road Medical. Boston Scientific Corporation (“Boston Scientific”) (NYSE:...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Warburg Pincus; Kirkland & Ellis acted for Everise. Warburg Pincus, a leading global growth investor, completed a US$1 billion investment in Everise, a leading...
You must be a Standard 1 Year member to access this content.
Latham & Watkins is advising Revolution Medicines on the offering, and Davis Polk is advising the underwriters involved. Revolution Medicines, Inc. (Nasdaq: RVMD) has announced the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented LG Chem in the transaction, while WilmerHale LLP represented AVEO. LG Chem, Ltd. (KOSPI: 051910) entered into a definitive agreement to acquire...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Nordic Capital in the transaction. Nordic Capital, a leading private equity investor, and Equashield have announced that Nordic Capital has joined Equashield’s...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Revolution Medicines, while Davis Polk advised the underwriters in the offering. Revolution Medicines, Inc. (Nasdaq: RVMD), has announced the pricing of its underwritten...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented CooperCompanies in the transaction. CooperCompanies has announced it has signed a binding letter of intent to acquire Cook Medical’s Reproductive Health business, a manufacturer...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented TransUnion in the transaction while Sidley advised nThrive. TransUnion (NYSE: TRU) has signed a definitive agreement to sell TransUnion Healthcare, Inc. to...
You must be a Standard 1 Year member to access this content.
Latham & Watkins LLP represented Imago BioSciences, Inc. in the offering. Imago BioSciences, Inc. (Imago) (NASDAQ: IMGO), a clinical stage biopharmaceutical company discovering new medicines for the...
You must be a Standard 1 Year member to access this content.
